CVRx Launches Next-Generation Barostim Neo2 Implantable Puls

November 14, 2022—CVRx, Inc., developer of the FDA-approved Barostim neuromodulation device to treat the symptoms of heart failure, recently ann

Related Keywords

Georgia , United States , Piedmont Atlanta , Barostim Neo , Michael Hoosien , Cvrx Barostim , Cvrx Inc , Barostim Programmer , Heart Failure , Neuromodulation , Arostim , Pg , Implantable Pulse Generator , Aroreflex , Da Breakthrough , Hypertension ,